...
首页> 外文期刊>Respiratory medicine >The effect of oral corticosteroids on bronchodilator responses in COPD.
【24h】

The effect of oral corticosteroids on bronchodilator responses in COPD.

机译:口服皮质类固醇对COPD中支气管扩张药反应的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

There have been suggestions that corticosteroid treatment might improve bronchodilator responses in chronic obstructive pulmonary disease (COPD). We have studied bronchodilator responses to salbutamol and to oxitropium bromide in 20 patients with stable moderate to severe COPD. Dose responses to the two bronchodilators were tested before and after 3 week courses of placebo and 30 mg prednisolone. Thirteen patients were taking inhaled corticosteroids. There were no significant changes in numbers of responses or maximum bronchodilator effects from either bronchodilator, although there was a trend towards higher maximum levels after 3 weeks of prednisolone. Spirometry measured at home each morning before and after oxitropium bromide showed no difference between prednisolone and placebo periods. This study provides no evidence for a significant effect on bronchodilator responses to beta-agonists or anticholinergic agents from 3 weeks of oral prednisolone in moderately severe COPD.
机译:有建议认为,糖皮质激素治疗可改善慢性阻塞性肺疾病(COPD)中的支气管扩张药反应。我们已经研究了20例中度至重度COPD稳定患者的支气管扩张剂对沙丁胺醇和溴托氧铵的反应。在安慰剂和30 mg泼尼松龙3周疗程之前和之后,测试了对两种支气管扩张药的剂量反应。 13名患者正在服用吸入糖皮质激素。尽管泼尼松龙3周后有最高水平升高的趋势,但两种支气管扩张剂的反应数量或最大支气管扩张剂作用均无明显变化。每天早晨在溴索托氧铵之前和之后在家中进行肺活量测定,结果显示泼尼松龙和安慰剂期间无差异。这项研究没有证据表明在中度重度COPD患者口服泼尼松龙3周后,其对β-激动剂或抗胆碱能药物的支气管扩张药反应有显著作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号